GIST Trials

Trial Name

Subtype

Agents

Phase

Status

Sponsor

Peak: CGT9486+Sunitinib vs. Sunitinib in GIST

Advanced GIST

CGT9486 (Bezuclastinib) and Sunitinib

III

Closed for recruitment, but active

Cogent Biosciences, Inc.

IDRX-42 in advanced GIST

Advanced GIST

IDRX-42

I

Open, recruiting

IDRx Inc

INSIGHT: Ripretinib vs. sunitinib

Advanced GIST

Ripretinib vs. Sunitinib

III

Open, recruiting

Deciphera Pharmaceuticals

REGISTRI

KIT/PDGFR wild type GIST

Regorafenib

II

Closed for recruitment

Grupo Espanol de Investigacion en Sarcomas

SSG XXII: 3 vs. 5 years of adjuvant imatinib

Operable GIST

Imatinib

III

Closed for recruitment, but active

Scandinavian Sarcoma Group (SSG)